Nippon India Nifty Pharma ETF-Growth
Equity: Sectoral-Pharma - Growth (Open ended) Factsheet
SEBI Riskometer: Very HighCategory: Equity: Sectoral-PharmaBenchmark: NIFTY Pharma Total Return Index
₹26.73+1.55%
27 Jul 2026
Tracking Difference
Annualised return gap between Nippon India Nifty Pharma ETF-Growth and its benchmark index over 1Y, 3Y, 5Y and 10Y periods, compared to the average of all funds tracking the same benchmark.
| Name | 1 Y | 3 Y | 5 Y | 10 Y |
|---|---|---|---|---|
| Fund | -0.26% | -0.32% | - | - |
| Avg. of funds with same benchmark | -0.26% | -0.32% | - | - |
Rolling Returns Analysis
Rolling annualized returns of Nippon India Nifty Pharma ETF-Growth across 1Y, 3Y and 5Y windows — average, best, worst returns and percentage of positive return periods.
| Metric | 1 Yr Rolling Returns | 3 Yr Rolling Returns | 5 Yr Rolling Returns | 7 Yr Rolling Returns |
|---|---|---|---|---|
| Analysis period | 08 Jul, 2022 - 27 Jul, 2026 | 19 Jul, 2024 - 27 Jul, 2026 | 27 Jul, 2026 - 27 Jul, 2026 | - |
| Average returns | 16.68% | 20.30% | 12.90% | - |
| Standard deviation | 22.01% | 3.05% | - | - |
| Best returns | 64.12% 1 year ending on 11 Mar, 2024 | 26.24% 3 years ending on 27 May, 2026 | 12.90% 5 years ending on 27 Jul, 2026 | - |
| Worst returns | -14.86% 1 year ending on 26 Jul, 2022 | 12.68% 3 years ending on 19 Jul, 2024 | 12.90% 5 years ending on 27 Jul, 2026 | - |
| Period with positive return | 70.70% | 100.00% | 100.00% | - |
| Period with return > 5% | 63.20% | 100.00% | 100.00% | - |
| Period with return > 10% | 55.70% | 100.00% | 100.00% | - |
| Period with return > 15% | 42.90% | 97.01% | 0.00% | - |
| Beat % Category | 32.80% | 24.15% | 0.00% | - |
| Beat % Benchmark | 40.30% | 23.15% | 0.00% | - |
Trailing Returns
Point-to-point returns of Nippon India Nifty Pharma ETF-Growth vs category average for YTD, 1M, 6M, 1Y, 3Y, 5Y and 10Y periods — with category rank and total funds count.
0%
10%
20%
30%
40%
14.6%
15.1%
14.8%
YTD
4.1%
3.7%
4.1%
1 M
19.6%
21.4%
19.7%
6 M
14.8%
11.7%
14.7%
1 Y
20.8%
20.6%
46.6%
3 Y
13.7%
14.1%
14.0%
5 Y
13.7%
9.2%
10 Y
Fund
Equity: Sectoral-Pharma
NIFTY Pharma Total Return Index
| Name | YTD | 1 M | 6 M | 1 Y | 3 Y | 5 Y | 10 Y | Since Inception |
|---|---|---|---|---|---|---|---|---|
| Fund | 14.62% | 4.08% | 19.56% | 14.83% | 20.80% | 13.69% | - | 12.71% |
| Equity: Sectoral-Pharma | 15.08% | 3.68% | 21.44% | 11.66% | 20.56% | 14.15% | 13.73% | - |
| NIFTY Pharma Total Return Index | 14.79% | 4.12% | 19.72% | 14.69% | 46.56% | 13.97% | 9.17% | - |
| Rank in category | 13 | 13 | 17 | 5 | 6 | 8 | - | - |
| Funds in category | 27 | 30 | 27 | 26 | 16 | 11 | 4 | - |
Period Returns
Calendar-year, quarterly and monthly return history of Nippon India Nifty Pharma ETF-Growth. Toggle between bar chart and table view to analyse periodic performance trends.
Historical Performance
Track NAV movement and cumulative returns of Nippon India Nifty Pharma ETF-Growth across 1M, 6M, 1Y, 3Y, 5Y and since-inception periods. Compare SIP and lumpsum growth over time.
Compare performance with respect toAdd benchmark
Add benchmark
Frequently Asked Questions
What are the 1-year returns of Nippon India Nifty Pharma ETF-Growth?
Nippon India Nifty Pharma ETF-Growth has delivered a 1-year return of 14.83% as of 26 Jul 2026. During the same period, its benchmark NIFTY Pharma Total Return Index returned 14.69%. The fund has outperformed its benchmark over this period.
What are the 3-year returns of Nippon India Nifty Pharma ETF-Growth?
Nippon India Nifty Pharma ETF-Growth has delivered a 3-year CAGR of 20.80% as of 26 Jul 2026. Its benchmark NIFTY Pharma Total Return Index returned 46.56% CAGR over the same period. CAGR (Compounded Annual Growth Rate) is the right way to evaluate multi-year ETF performance as it smooths out year-to-year volatility.
What are the 5-year returns of Nippon India Nifty Pharma ETF-Growth?
Nippon India Nifty Pharma ETF-Growth has delivered a 5-year CAGR of 13.69% as of 26 Jul 2026. Its benchmark NIFTY Pharma Total Return Index returned 13.97% CAGR over the same period. A 5-year track record is considered a more reliable indicator of fund quality than shorter-term performance, as it captures at least one full market cycle.
What are the returns of Nippon India Nifty Pharma ETF-Growth since inception?
Since its launch on 12 Jul 2021, Nippon India Nifty Pharma ETF-Growth has delivered a CAGR of 12.71%. Since-inception returns reflect the fund's full history and give the most complete picture of long-term performance.
How has Nippon India Nifty Pharma ETF-Growth performed vs its category over the long term?
Over the long term, Nippon India Nifty Pharma ETF-Growth has ranked 6 out of 16 funds in the Equity: Sectoral-Pharma category on a 3-year basis, and 8 out of 11 funds on a 5-year basis. Category rank is one of several factors to consider alongside risk metrics and rolling return consistency when evaluating a fund.
What is the Sharpe ratio of Nippon India Nifty Pharma ETF-Growth?
The Sharpe ratio of Nippon India Nifty Pharma ETF-Growth is 1.00 (as of 26 Jul 2026). The Sharpe ratio measures how much return the fund generates per unit of risk (volatility) taken. A Sharpe ratio above 1.0 is generally considered good — the higher the ratio, the better the risk-adjusted return.
What is the alpha of Nippon India Nifty Pharma ETF-Growth?
The 3Y alpha of Nippon India Nifty Pharma ETF-Growth is -0.53% (as of 26 Jul 2026). Alpha measures the excess return generated by the fund over and above its benchmark NIFTY Pharma Total Return Index, after adjusting for risk. A positive alpha means the fund manager has added value beyond what the market delivered. A negative alpha means the fund has underperformed its benchmark on a risk-adjusted basis.
What is the beta of Nippon India Nifty Pharma ETF-Growth?
The beta of Nippon India Nifty Pharma ETF-Growth is 0.95 (as of 26 Jul 2026). Beta measures how sensitive the fund is to market movements relative to its benchmark NIFTY Pharma Total Return Index. A beta of 1 means the fund moves in line with the market. A beta above 1 means it is more volatile than the market; below 1 means it is less volatile. Nippon India Nifty Pharma ETF-Growth's beta of 0.95 indicates it is more defensive than its benchmark.
What are the rolling returns of Nippon India Nifty Pharma ETF-Growth?
The average 1-year and 3-year rolling returns of Nippon India Nifty Pharma ETF-Growth is 16.68% and 20.30% respectively. Rolling returns show the fund's annualized return across every possible 1-year and 3-year investment window, making them a far more reliable measure of consistency than point-to-point returns, which depend heavily on the start and end date chosen.